Mapping of the International Classification of Functioning, Disability and Health categories in the Pre-Assessment Information Form for People with Parkinson’s Disease.
Objective: Perform the linkage between the items of the Pre-Assessment Information Form (PAIF) of the people with Parkinson's Disease (pPD) with the categories of the…Finely tuned gamma oscillations across the motor system in patients with isolated dystonia implanted with sensing-enabled pulse generators
Objective: To characterize the functional role of finely tuned gamma (FTG) oscillations across the motor network in freely-moving patients with dystonia. Background: FTG has been…Impact of the dopamine system on long-term, incident cognitive impairment in Parkinson disease
Objective: To determine the impact of the dopamine system (dopamine transporter [DAT] availability, dopamine-related SNPs, and dopaminergic medication use) on long-term cognitive performance in early…DNA methylation differs between idiopathic Parkinson Disease and Healthy Control subjects in the Parkinson’s Progression Marker Initiative (PPMI) cohort
Objective: Compare baseline whole blood DNA methylation in unmedicated idiopathic Parkinson's Disease (iPD) and healthy control (HC) participants from PPMI Background: Epigenetic mechanisms like DNA…POOR SLEEP QUALITY AND OBESITY IN PATIENTS WITH PARKINSON’S: PRELIMINARY RESULTS OF A COHORT STUDY
Objective: Describe the prevalence of overweight and obesity in patients with PD who have poor quality sleep. Background: Sleep disturbances are common and often severe…Worsening tic disorder: Expanding the phenotype of IgLON5 disease
Objective: To report on the possible association of motor tics and anti-IgLON5 disease Background: Anti-IgLON5 disease is an antibody-mediated neurodegenerative syndrome characterised by sleep disorders,…Psychosis in Parkinson’s disease and polymorphisms of the HOMER1 and COMT genes: Is there an association?
Objective: To investigate if polymorphisms of the HOMER1 and COMT gene are associated with psychosis in Parkinson’s disease (PD). Background: Psychosis is one of the…Limb myorhythmia treated with chemodenervation: A case report
Objective: To describe the case of a patient with limb myorhythmia successfully treated with bolutinum toxin injections. Background: Myorhythmia is a rare condition characterized by…Activity and sleep associated with changes in glymphatic imaging-markers in Parkinson Disease patients enrolled in 3-month exercise program
Objective: To investigate whether intensity of activity and quality of sleep during a 3-month exercise program for patients with Parkinson Disease (PD) are associated with…Prevalence of sleep disorders in Parkinson’s disease patients at a Brazilian movement disorders center in 2022
Objective: To describe the prevalence of the main sleep disorders in patients with Parkinson's disease at a referral outpatient clinic for movement disorders. Background: Parkinson's…
- « Previous Page
- 1
- …
- 376
- 377
- 378
- 379
- 380
- …
- 1554
- Next Page »